Literature DB >> 23154716

Postpartum migraines: a long-term prospective study.

Eisei Hoshiyama1, Muneto Tatsumoto, Hisatake Iwanami, Akihiro Saisu, Hiroshi Watanabe, Noriyuki Inaba, Koichi Hirata.   

Abstract

OBJECTIVE: There are many reports regarding the course of migraines during pregnancy. However, the prevalence and characteristics of migraines during the postpartum period have not been adequately investigated. We prospectively investigated the patients suffering from migraines over a long postpartum period in an obstetrics department in Japan.
METHODS: We investigated the course of migraines experienced during the postpartum period by patients in a postnatal ward. The patients were surveyed during the first postpartum week and 1, 3, 6 and 12 months after delivery. The patients were provided a headache diary to assess medication use and migraine attack frequency, severity (the faces pain scale) and duration.
RESULTS: The migraine remission rate was 63%, 83% and 85% during the first, second and third trimesters, respectively. No patient experienced a worsening of headaches during pregnancy. Headache recurrence during the first month after delivery was more frequent in the patients >30 years of age than in those ≤30 years of age (p<0.05). The percentage of women experiencing recurrence at 1, 3, 6 and 12 months after delivery was 63%, 75%, 78% (n=60) and 87.5% (n=40), respectively. In breastfeeding patients, the rates were 50%, 65.8%, 71.1% and 91.7% and in bottle feeding patients, the rates were 86.4%, 90.9%, 95.5% and 81.3%, respectively.
CONCLUSION: We found that 85% of the patients with migraines experience remission during pregnancy and that more than 50% experience recurrence during the first month after delivery. Until six months after delivery, breastfeeding is associated with a lower recurrence rate than bottle feeding.

Entities:  

Mesh:

Year:  2012        PMID: 23154716     DOI: 10.2169/internalmedicine.51.8542

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

Review 1.  Women and Migraine: the Role of Hormones.

Authors:  Candice Todd; Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-31       Impact factor: 5.081

Review 2.  Migraine in pregnancy and lactation.

Authors:  Paru S David; Juliana M Kling; Amaal J Starling
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

Review 3.  Pharmacological treatment of migraine during pregnancy and breastfeeding.

Authors:  Siri Amundsen; Hedvig Nordeng; Kateřina Nezvalová-Henriksen; Lars Jacob Stovner; Olav Spigset
Journal:  Nat Rev Neurol       Date:  2015-04       Impact factor: 42.937

Review 4.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 5.  Breastfeeding and migraine drugs.

Authors:  Riccardo Davanzo; Jenny Bua; Giulia Paloni; Giulia Facchina
Journal:  Eur J Clin Pharmacol       Date:  2014-09-13       Impact factor: 2.953

Review 6.  Managing Migraine During Pregnancy and Lactation.

Authors:  Rebecca Erwin Wells; Dana P Turner; Michelle Lee; Laura Bishop; Lauren Strauss
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 7.  Targeted Orexin and Hypothalamic Neuropeptides for Migraine.

Authors:  Lauren C Strother; Anan Srikiatkhachorn; Weera Supronsinchai
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

8.  Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study.

Authors:  Azize Boström; Dirk Scheele; Birgit Stoffel-Wagner; Frigga Hönig; Shafqat R Chaudhry; Sajjad Muhammad; Rene Hurlemann; Joachim K Krauss; Ilana S Lendvai; Krishnan V Chakravarthy; Thomas M Kinfe
Journal:  J Transl Med       Date:  2019-02-22       Impact factor: 5.531

Review 9.  Leptin and Associated Mediators of Immunometabolic Signaling: Novel Molecular Outcome Measures for Neurostimulation to Treat Chronic Pain.

Authors:  Thomas M Kinfe; Michael Buchfelder; Shafqat R Chaudhry; Krishnan V Chakravarthy; Timothy R Deer; Marc Russo; Peter Georgius; Rene Hurlemann; Muhammad Rasheed; Sajjad Muhammad; Thomas L Yearwood
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

10.  Functional gene networks reveal distinct mechanisms segregating in migraine families.

Authors:  Andreas H Rasmussen; Lisette J A Kogelman; David M Kristensen; Mona Ameri Chalmer; Jes Olesen; Thomas Folkmann Hansen
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.